No worries at all! I hope you feel more welcomed from now on as I know everyone else would highly value your opinion and looks forward to all your future contributions . I’m sure I can speak on behalf of everyone else that we are thrilled to have a large investor in the medical imaging field. Emvision imo is heavily derisked with huge growth potential. It’s very exciting to have been validated that the scanner can distinguish between a clot and a bleed as we await the trial to conclude and deliver its final review. As you pointed out it’s also great to see emvision scanner has minimal radiation. the possible competitor with micro x I feel there not even in the same ball park - they seem to have far to many directions they’re trying to go with no cash. In comparison with our team verse micro x team again the comparison in caliber of employees and there backgrounds are next level. The way emvision has cleverly collaborated with keysight to help with reducing the size and again in the latest update indicated they could reduce the size further is monumental. Basicly I think every step a competitor takes , emvision will pull 3 steps further ahead.
and yes I have been a investor since ipo , participated in every raise & continued to buy on market and will continue to do so ! good luck to all
EMV Price at posting:
$1.80 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)